A Brucella melitensis H38¿wbkF rough mutant protects against Brucella ovis in rams
Resumen: Brucella melitensis and Brucella ovis are gram-negative pathogens of sheep that cause severe economic losses and, although B. ovis is non-zoonotic, B. melitensis is the main cause of human brucellosis. B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with an N-formyl-perosamine O-polysaccharide (O-PS) that is absent in the rough LPS of B. ovis. Their control and eradication require vaccination, but B. melitensis Rev 1, the only vaccine available, triggers anti-O-PS antibodies that interfere in the S-brucellae serodiagnosis. Since eradication and serological surveillance of the zoonotic species are priorities, Rev 1 is banned once B. melitensis is eradicated or where it never existed, hampering B. ovis control and eradication. To develop a B. ovis specific vaccine, we investigated three Brucella live vaccine candidates lacking N-formyl-perosamine O-PS: Bov::CAΔwadB (CO2-independent B. ovis with truncated LPS core oligosaccharide); Rev1::wbdRΔwbkC (carrying N-acetylated O-PS); and H38ΔwbkF (B. melitensis rough mutant with intact LPS core). After confirming their attenuation and protection against B. ovis in mice, were tested in rams for efficacy. H38ΔwbkF yielded similar protection to Rev 1 against B. ovis but Bov::CAΔwadB and Rev1::wbdRΔwbkC conferred no or poor protection, respectively. All H38ΔwbkF vaccinated rams developed a protracted antibody response in ELISA and immunoprecipitation B. ovis diagnostic tests. In contrast, all remained negative in Rose Bengal and complement fixation tests used routinely for B. melitensis diagnosis, though some became positive in S-LPS ELISA owing to LPS core epitope reactivity. Thus, H38ΔwbkF is an interesting candidate for the immunoprophylaxis of B. ovis in B. melitensis-free areas.
Idioma: Inglés
DOI: 10.1186/s13567-022-01034-z
Año: 2022
Publicado en: Veterinary Research 53 (2022), [13 pp.]
ISSN: 0928-4249

Factor impacto JCR: 4.4 (2022)
Categ. JCR: VETERINARY SCIENCES rank: 6 / 144 = 0.042 (2022) - Q1 - T1
Factor impacto CITESCORE: 6.4 - Veterinary (Q1)

Factor impacto SCIMAGO: 0.869 - Veterinary (miscellaneous) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/DGA/A13-17R
Financiación: info:eu-repo/grantAgreement/ES/DGA/A21-20R
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PID2019-107601RB-C31
Financiación: info:eu-repo/grantAgreement/ES/MINECO/AGL2014-58795-C4-1-R
Financiación: info:eu-repo/grantAgreement/ES/MINECO/AGL2014-58795-C4-3-R
Financiación: info:eu-repo/grantAgreement/ES/MINECO/AGL2014-58795-C4-4-R
Financiación: info:eu-repo/grantAgreement/ES/MINECO/BES-2015-075609
Tipo y forma: Article (Published version)
Área (Departamento): Área Sanidad Animal (Dpto. Patología Animal)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2025-02-14-14:11:20)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Sanidad Animal



 Record created 2023-01-11, last modified 2025-02-14


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)